Social Vulnerability and Sickle Cell Disease Mortality in the US
JAMA Network Open · 2024
DOI: 10.1001/jamanetworkopen.2024.40599 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2024. Verfasst von Jia Yi Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, New York Medical College at St Michael's Medical Center, Newark, New Jersey. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Social Vulnerability, Social Determinants of Health. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Social determinants of health (SDOH) influence health outcomes, including those of sickle cell disease (SCD), despite advancements in treatments like disease-modifying therapies.
Objective
To investigate the association of SDOH with SCD mortality rates from 2016 to 2020. Design, Setting, and Participants This cross-sectional study combined county-level data from the Centers for Disease Control and Prevention and Agency for Toxic Substances and Disease Registry Social Vulnerability Index (SVI) with SCD mortality data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database from January 1, 2016, to December 31, 2020. US counties were divided into 4 quartile (Q) models according to their SVI scores. Deaths from SCD in the US among patients of all ages were included. Data analysis occurred from March to April 2024. Exposure SVI score. Main Outcomes and Measures Age-adjusted mortality rates (AAMRs) per 1 000 000 individuals were measured. Rate ratios (RRs) were obtained by comparing county-specific AAMRs of SVI-Q4 with SVI-Q1.
Results
From 2016 to 2020, among a total population of 1 633 737 771 individuals, there were 2635 deaths from SCD (1289 male [49.1%] and 1336 female [50.9%]). There were 1480 deaths in Q4, 687 deaths in Q3, 344 deaths in Q2, and 114 deaths in Q1. Higher SVI was associated with 2.11 excess deaths per 1 000 000 individuals (RR, 4.90; 95% CI, 4.81-5.00). Similar trends were seen for both males (RR, 4.56; 95% CI, 4.44-4.69) and females (RR, 5.85; 95% CI, 5.68-6.03). Middle-aged patients with SCD had the highest mortality rate in Q4, with 3.45 excess deaths per 1 000 000 individuals (RR, 4.97; 95% CI, 4.85-5.09). Higher SVI was associated with 2.29 excess deaths per 1 000 000 individuals in African American individuals with SCD (RR, 1.24; 95% CI, 1.22-1.27]). In White individuals with SCD, higher SVI was associated with 0.12 excess deaths per 1 000 000 individuals (RR not available due to unreliable data in Q1). When stratifying by census region, the highest level of SCD-related mortality was in the Northeast, with higher SVI associated with 3.16 excess deaths per 1 000 000 individuals (RR, 8.02; 95% CI, 7.66-8.40).
Conclusions
In this cross-sectional study of the association of SVI with SCD mortality rates, higher SVI was associated with higher SCD mortality across US counties. These findings underscore the importance of addressing social determinants of health to improve mortality outcomes among patients with SCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, New York Medical College at St Michael's Medical Center, Newark, New Jersey.
- Department of Internal Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York.
- Department of Internal Medicine and Pediatrics, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan.
- Division of Hematology and Oncology, Department of Internal Medicine, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth Houston).
- Division of Hematology and Oncology, Department of Internal Medicine, New York Medical College at St Michael's Medical Center, Newark, New Jersey.
- Department of Hematology and Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.
Zitieren
APA
Tan, J. Y., San, B. J., Yeo, Y. H., Chan, K. H., Shaaban, H. S., Ezekwudo, D. E., & Idowu, M. (2024). Social Vulnerability and Sickle Cell Disease Mortality in the US. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.40599
Vancouver
Tan JY, San BJ, Yeo YH, Chan KH, Shaaban HS, Ezekwudo DE, et al. Social Vulnerability and Sickle Cell Disease Mortality in the US. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.40599
BibTeX
@article{Tan2024,
author = {Tan, Jia Yi and San, Boon Jian and Yeo, Yong-Hao and Chan, Kok Hoe and Shaaban, Hamid S and Ezekwudo, Daniel E and Idowu, Modupe},
title = {Social Vulnerability and Sickle Cell Disease Mortality in the US},
journal = {JAMA Network Open},
year = {2024},
doi = {10.1001/jamanetworkopen.2024.40599}
}
EUVIMED